Secondary Logo

Journal Logo

August 2016 - Volume 39 - Issue 4
pp: 321-426



Gynecologic


Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma

Nagar, Himanshu; Yan, Weisi; Parashar, Bhupesh; More

American Journal of Clinical Oncology. 39(4):335-339, August 2016.

Gastrointestinal


Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study

Burtness, Barbara; Powell, Mark; Catalano, Paul; More

American Journal of Clinical Oncology. 39(4):340-345, August 2016.

Thoracic


Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy

Lee, Victor H.F.; Chan, Wendy W.L.; Lee, Elaine Y.P.; More

American Journal of Clinical Oncology. 39(4):355-362, August 2016.

Breast


Genitourinary


The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer

Bian, Shelly X.; Kuban, Deborah A.; Levy, Lawrence B.; More

American Journal of Clinical Oncology. 39(4):368-373, August 2016.

Endocrine


Central Nervous System



ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II

Roberts, Kenneth B.; Younes, Anas; Hodgson, David C.; More

American Journal of Clinical Oncology. 39(4):384-395, August 2016.